Surface Oncology, Inc.
SURF · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $15 | $29 | $51 | $65 |
| Short-Term Investments | $41 | $73 | $74 | $81 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | -$0 | $0 |
| Other Curr. Assets | $4 | $5 | $4 | $4 |
| Total Curr. Assets | $61 | $107 | $129 | $150 |
| Property Plant & Equip (Net) | $5 | $28 | $29 | $30 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $2 | $2 | $2 |
| Total NC Assets | $5 | $30 | $31 | $31 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $66 | $137 | $160 | $182 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $0 | $1 |
| Short-Term Debt | $9 | $6 | $6 | $6 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $8 | $10 | $12 |
| Total Curr. Liab. | $17 | $15 | $16 | $18 |
| LT Debt | $0 | $46 | $50 | $51 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $46 | $50 | $51 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $17 | $61 | $67 | $69 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$252 | -$224 | -$204 | -$183 |
| AOCI | -$0 | -$1 | -$1 | -$1 |
| Other Equity | $302 | $300 | $298 | $297 |
| Total Equity | $49 | $76 | $93 | $113 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $66 | $137 | $160 | $182 |
| Net Debt | -$5 | $23 | $5 | -$9 |